低温保护剂对人类肠道微生物和体外稳定的人工肠道微生物群体的影响
Giulia Alessandri1, Sonia Mirjam Rizzo1, Leonardo Mancabelli2,3
1Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.
Microbial biotechnology
|June 15, 2024
概括
有效的肠道细菌冷保存需要特定的药物. 胰岛素或脱脂牛奶与基于甘油的冷保护剂相结合,最好保持生物库中的细菌生存能力和生物多样性.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
背景情况:
- 微生物生物库对于肠道微生物群相互作用的体外研究至关重要.
- 在储存期间保持细菌活力需要有效的冷保存技术.
研究的目的:
- 评估七种冷保护剂组合在冷保存后对53种人类肠道细菌物种的生存能力的疗效.
- 评估冷保护剂对人工肠道微生物群的生存能力和生物多样性的影响.
主要方法:
- 53种细菌物种和10种人工肠道微生物群在-80°C下冷保存1个月和3个月.
- 使用流式细胞计量来评估冷保存后的细胞活力.
- 评估七种不同的冷保护剂组合.
主要成果:
- 没有任何一种单一的冷保护剂能够确保所有测试细菌的有效恢复.
- 胰岛素或脱脂牛奶显著提高了细菌的活力,并保护它们免受冷暴露.
- 人工肠道微生物群的冷保存显示,当纳入胰岛素或脱脂牛奶时,可活细胞的恢复率很高,生物多样性得到保护.
结论:
- 结晶保护剂的有效性是肠道细菌的物种特异性.
- 建议使用含有胰岛素或脱脂牛奶的基于糖的冷保护剂,以保持单一物种和人工肠道微生物群的生存能力和生物多样性.
相关概念视频
Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Stomach and Small Intestine
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Functions of the Gut Microbiota
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


